“You can’t teach fish to fly,” is one of the phrases that our CIRM President & CEO, Randy Mills, likes to throw out when asked why we needed to create new centers to help researchers move their most promising therapies out of the lab and into clinical trials. His point is that many researchers are … Continue reading If you want to accelerate stem cell therapies then create an Accelerating Center
C. Randal Mills
Board gives stem cell institute marching orders, and a road map
The poet T. S. Eliot once wrote: “If you aren't in over your head, how do you know how tall you are?” Well, everyone at CIRM, California’s stem cell institute, is about to find out how tall we are. Yesterday our governing Board approved a new Strategic Plan. To call it ambitious might be considered … Continue reading Board gives stem cell institute marching orders, and a road map
Doing nothing is not OK: A call for change at the FDA
The US Food and Drug Administration (FDA) is caught between a rock and a hard place. And CIRM is going to try and help them get out from under that. As things stand today, if the FDA approves a therapy quickly and a patient later dies from it, then they are widely criticized. If they … Continue reading Doing nothing is not OK: A call for change at the FDA
Stem cell stories that caught our eye: mini-brains in a dish, blood stem cells and state funded stem cell research
Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. Great review of brains in a dish. The veteran Associated Press science journalist Malcolm Ritter produced the most thorough overview I have seen of the … Continue reading Stem cell stories that caught our eye: mini-brains in a dish, blood stem cells and state funded stem cell research
Partnering with Big Pharma to benefit patients
Our mission at CIRM is to accelerate the development of stem cell therapies for patients with unmet medical needs. One way we have been doing that is funding promising research to help it get through what’s called the “Valley of Death.” This is the time between a product or project showing promise and the time … Continue reading Partnering with Big Pharma to benefit patients
Share your voice, shape our future
There is power in a single voice. I am always reminded of that whenever I meet a patient advocate and hear them talk about the need for treatments and cures – and not just for their particular disease but for everyone. The passion and commitment they display in advocating for more research funding reflects the … Continue reading Share your voice, shape our future